2018
DOI: 10.2217/rme-2018-0007
|View full text |Cite
|
Sign up to set email alerts
|

Selling Stem Cell ‘Treatments’ as Research: Prospective Customer Perspectives from Crowdfunding Campaigns

Abstract: The NIH, US FDA and others should be concerned about being co-opted to misrepresent the nature of these businesses' activities. Efforts are also needed to better inform those considering purchasing unproven stem cell interventions about their relationship to legitimate research.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
27
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8
1

Relationship

4
5

Authors

Journals

citations
Cited by 24 publications
(27 citation statements)
references
References 35 publications
0
27
0
Order By: Relevance
“…Previous analyses of these campaigns have flagged the Burzynski clinic in Texas, the Hallwang Private Oncology Clinic in Germany, and providers selling the Gerson therapy as a cancer treatment as engaging in misleading marketing or selling products that may put patients at risk [15]. Moreover, studies of crowdfunding campaigns for alternative or unproven interventions have found that these campaigners often repeat and exaggerate misinformation about the safety and efficacy of these interventions, use markers of scientific legitimacy to support their campaigns, and are used to fund ineffective and potentially dangerous interventions [18][19][20][21]. This is not surprising given that these campaigns must reassure potential donors of the value of these interventions and that their money will be well spent.…”
Section: Introductionmentioning
confidence: 99%
“…Previous analyses of these campaigns have flagged the Burzynski clinic in Texas, the Hallwang Private Oncology Clinic in Germany, and providers selling the Gerson therapy as a cancer treatment as engaging in misleading marketing or selling products that may put patients at risk [15]. Moreover, studies of crowdfunding campaigns for alternative or unproven interventions have found that these campaigners often repeat and exaggerate misinformation about the safety and efficacy of these interventions, use markers of scientific legitimacy to support their campaigns, and are used to fund ineffective and potentially dangerous interventions [18][19][20][21]. This is not surprising given that these campaigns must reassure potential donors of the value of these interventions and that their money will be well spent.…”
Section: Introductionmentioning
confidence: 99%
“…Similarly, a study of campaigns for unproven stem cell interventions found that 43.6 percent made definitive statements about the efficacy of these interventions, and none stated concerns with their potential risks . These campaigns also often falsely presented these interventions as part of clinical trials, as having support from the National Institutes of Health, and as having U.S. Food and Drug Administration (FDA) approval . Extremely optimistic and unsupported claims about the efficacy of stem cell interventions have been found elsewhere as well .…”
Section: The Case For Prohibitionmentioning
confidence: 99%
“…Patients are financially exploited and charged from around $3500 to a whopping $400,000, excluding travel expenses (Matthews & Iltis, 2015). Insurance companies mostly do not cover these and the costs from the subsequent side effects, therefore the money often comes from communities and crowd-funding campaigns with emotional narratives (Turner, 2010;Abou-El-Enein et al, 2016;Snyder & Turner, 2018;Snyder et al, 2018).…”
Section: The Growing Phenomenon Of Stem Cell Tourism Financial Explomentioning
confidence: 99%